HMGCR and lung cancer: Originally for treating cardiovascular diseases, statins like HMGCR inhibitors have become a standard of care for treating cancer patients with high cholesterol levels (199, 200) and also reduce the incidence and recurrence of various cancers, including colon (201), liver (202), and lung cancer (203).